DHL Supply Chain has announced its acquisition of SDS Rx, a U.S. provider of final-mile delivery and specialized healthcare transportation, pending regulatory approvals. This move enhances DHL’s healthcare capabilities by adding services for long-term care, specialty pharmacies, and health systems, while integrating SDS Rx’s operations into its North American Life Sciences and Healthcare business. The acquisition aligns with the growing demand in the healthcare sector and supports DHL’s Strategy 2030 to bolster its logistics portfolio in life sciences and healthcare.